Given that NF-κB and p38 MAP kinase are responsible for ORM2-mediated regulation of IL-6 and CXCL8 production, we presume that these signaling pathways can link GYPC receptor activation to cytokine expression in ORM2-stimulated RA-FLSs. The gene discussed is IL6; the disease is rheumatoid arthritis.